Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: A sub analysis of the Treat to Target post authorization survey. Prospective observational, two armed study in 14,200 patients

OBJECTIVES: The metabolic syndrome is a cluster of cardiovascular risk factors leading to an increased risk for the subsequent development of diabetes and cardiovascular morbidity and mortality. Blocking the renin-angiotensin system has been shown to prevent cardiovascular disease and delay the onse...

Descripción completa

Detalles Bibliográficos
Autores principales: Kintscher, Ulrich, Bramlage, Peter, Paar, W Dieter, Thoenes, Martin, Unger, Thomas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2007
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853076/
https://www.ncbi.nlm.nih.gov/pubmed/17407587
http://dx.doi.org/10.1186/1475-2840-6-12

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1853076/
https://www.ncbi.nlm.nih.gov/pubmed/17407587
http://dx.doi.org/10.1186/1475-2840-6-12

Ejemplares similares